ReP USP - Resultado da busca

Filtros : "Indexado no Biobase" "Indexado no Excerpta Medica" "LEUCEMIA" Removidos: "POLÍTICA" "FMRP-ROO" "MENDONÇA, BERENICE BILHARINHO DE" Limpar

Filtros

Artigo de periodico
DNA methylation analysis of the tumor suppressor gene CDKN2B in Brazilian leukemia patients (2008)
Lima, Patrícia Santos Pereira; Molffeta, Greice Andreoti; Araújo, Amélia Góes de; Zago, Marco Antônio; Silva Júnior, Wilson Araújo da
Source: Genetics and Molecular Biology. Unidade: FMRP
Subjects: LEUCEMIA, DNA, GENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Patrícia Santos Pereira et al. DNA methylation analysis of the tumor suppressor gene CDKN2B in Brazilian leukemia patients. Genetics and Molecular Biology, v. 31, n. 3, p. 632-638, 2008Tradução . . Disponível em: https://doi.org/10.1590/s1415-47572008000400005. Acesso em: 12 set. 2024.
APA
Lima, P. S. P., Molffeta, G. A., Araújo, A. G. de, Zago, M. A., & Silva Júnior, W. A. da. (2008). DNA methylation analysis of the tumor suppressor gene CDKN2B in Brazilian leukemia patients. Genetics and Molecular Biology, 31( 3), 632-638. doi:10.1590/s1415-47572008000400005
NLM
Lima PSP, Molffeta GA, Araújo AG de, Zago MA, Silva Júnior WA da. DNA methylation analysis of the tumor suppressor gene CDKN2B in Brazilian leukemia patients [Internet]. Genetics and Molecular Biology. 2008 ; 31( 3): 632-638.[citado 2024 set. 12 ] Available from: https://doi.org/10.1590/s1415-47572008000400005
Vancouver
Lima PSP, Molffeta GA, Araújo AG de, Zago MA, Silva Júnior WA da. DNA methylation analysis of the tumor suppressor gene CDKN2B in Brazilian leukemia patients [Internet]. Genetics and Molecular Biology. 2008 ; 31( 3): 632-638.[citado 2024 set. 12 ] Available from: https://doi.org/10.1590/s1415-47572008000400005
Artigo de periodico
Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices (2008)
Mannello, Ferdinando; Tanus-Santos, José Eduardo; Meschiari, Cesar A.; Tonti, Gaetana A.
Source: Analytical Biochemistry. Unidade: FMRP
Subjects: METALOPROTEINASES, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANNELLO, Ferdinando et al. Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices. Analytical Biochemistry, v. 374, n. 1, p. 56-63, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ab.2007.11.020. Acesso em: 12 set. 2024.
APA
Mannello, F., Tanus-Santos, J. E., Meschiari, C. A., & Tonti, G. A. (2008). Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices. Analytical Biochemistry, 374( 1), 56-63. doi:10.1016/j.ab.2007.11.020
NLM
Mannello F, Tanus-Santos JE, Meschiari CA, Tonti GA. Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices [Internet]. Analytical Biochemistry. 2008 ; 374( 1): 56-63.[citado 2024 set. 12 ] Available from: https://doi.org/10.1016/j.ab.2007.11.020
Vancouver
Mannello F, Tanus-Santos JE, Meschiari CA, Tonti GA. Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices [Internet]. Analytical Biochemistry. 2008 ; 374( 1): 56-63.[citado 2024 set. 12 ] Available from: https://doi.org/10.1016/j.ab.2007.11.020

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024